Bayer UK and Ireland appoints new CEO

Bayer has appointed a new UK and Ireland CEO in the form of Lars Bruening, who moves to its Reading, UK base from Berlin where he was head of the pharma group’s global market access business.

Prior to that Bruening held senior commercial roles in Europe, the Middle East and Asia, bringing knowledge in the pharmaceutical sector, international healthcare landscape and global commercial markets to the group.

He said: “Looking in from afar, the progress the UK and Ireland has made over the last four years alone, with the UK becoming the third largest Bayer market in Europe and the eighth largest in the world, as well as the progress made in individual markets also reflects the ongoing work with our partners and colleagues at the grassroots levels.

“It is this, which I am incredibly proud of and look forward to building upon this existing success.”

Bruening succeeds Alexander Moscho, who left Bayer after seven years to join UCB as its chief strategy officer.